IBOV 177,547.57 ▲ 2.44% IPSA 11,009.22 ▲ 0.50% IPC MEX 67,303.83 ▲ 0.88% MERVAL 3,379,771 ▲ 2.98% COLCAP 2,297.00 ▼ 0.19% BVL PERÚ 57,575.02 — — USD/BRL5.05▼ 0.37% USD/MXN17.38▼ 0.17% USD/CLP937.27▲ 0.17% USD/COP3,205▼ 1.57% USD/PEN3.40▼ 0.04% USD/ARS1,482▲ 0.30% USD/UYU40.14▲ 1.07% USD/PYG6,035▲ 1.50% USD/BOB10.95▲ 3.79% USD/DOP58.15▼ 0.09% USD/CRC447.42▲ 1.35% USD/GTQ7.62▲ 2.27% USD/HNL26.74▲ 1.52% USD/NIO36.62▲ 0.72% USD/VES736.04▼ 0.04% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD156.98▲ 0.03% USD/TTD6.71▲ 0.76% EUR/BRL5.77▼ 0.88% BRENT 95.83 ▲ 5.30% WTI 88.16 ▲ 3.83% IRON ORE 161.91 — — COPPER 6.51 ▼ 0.07% GOLD 4,117 ▲ 1.13% SILVER 59.74 ▲ 1.54% SOY 1,242 ▲ 1.87% CORN 485.00 ▲ 7.12% WHEAT 705.50 ▲ 4.06% COFFEE 318.05 ▼ 4.19% SUGAR 14.75 ▼ 0.87% ORANGE JUICE 147.50 ▲ 2.57% COTTON 81.36 ▲ 3.04% COCOA 5,353 ▼ 4.53% BEEF 219.20 ▼ 3.30% CATTLE 336.15 ▼ 3.83% LITHIUM 69.00 ▼ 0.12% PETR4 42.58 ▲ 2.21% VALE3 75.10 ▲ 3.77% ITUB4 42.90 ▲ 0.87% BBDC4 18.97 ▲ 2.26% ABEV3 16.13 ▲ 2.09% BBAS3 21.09 ▲ 1.01% B3SA3 15.90 ▲ 4.81% WEGE3 46.74 ▲ 10.05% PRIO3 59.77 ▲ 2.73% SUZB3 42.66 ▲ 2.47% RENT3 37.14 ▲ 1.61% AZZA3 17.81 ▲ 1.89% CSAN3 3.92 ▲ 3.70% RAIZ4 0.27 — 0.00% PCAR3 2.75 ▲ 0.73% GMAT3 3.91 ▲ 2.09% PSSA3 55.45 ▲ 3.68% CVCB3 1.27 ▲ 13.39% POSI3 3.70 ▲ 0.54% SLCE3 13.96 ▲ 1.53% NATU3 8.68 ▼ 0.34% BRKM5 6.07 ▲ 6.30% RANI3 8.00 ▲ 1.39% CSNA3 5.38 ▲ 6.32% CMIN3 5.84 ▲ 4.66% USIM5 8.65 ▲ 2.25% GGBR4 24.06 ▲ 2.43% ENEV3 25.97 ▲ 2.16% CPFE3 46.71 ▲ 0.67% CMIG4 11.21 ▲ 1.72% EQTL3 39.35 ▲ 1.34% LREN3 13.54 ▲ 2.03% VIVT3 35.38 ▼ 1.17% RAIL3 13.64 ▲ 3.02% KLABIN 17.93 ▲ 1.93% RAIA DROGASIL 18.29 ▲ 0.88% RDOR3 34.49 ▲ 1.68% HAPV3 11.39 ▲ 1.33% FLRY3 16.65 ▲ 0.60% SMTO3 16.05 ▲ 3.02% UGPA3 32.83 ▲ 3.17% VBBR3 34.98 ▲ 3.03% BBSE3 42.58 ▲ 2.48% BPAC11 57.02 ▲ 2.98% CURY3 30.20 ▲ 0.83% AERI3 2.05 ▲ 0.49% VIVARA 21.55 ▲ 0.65% COMPASS 24.81 ▲ 1.51% VAMOS 3.23 ▲ 4.53% SANB11 26.95 ▼ 0.96% ASAI3 8.40 ▲ 1.82% SBSP3 29.29 ▲ 2.41% WALMEX 48.65 ▼ 1.02% GMEXICO 214.34 ▲ 2.57% FEMSA 227.98 ▲ 0.55% CEMEX 22.17 ▲ 0.45% GFNORTE 191.99 ▲ 3.33% BIMBO 60.30 ▲ 1.53% TELEVISA 9.82 ▲ 0.61% AMX 22.70 ▼ 0.26% GAP 378.40 ▼ 0.03% ASUR 273.53 ▼ 0.52% OMA 229.62 ▲ 1.49% KOF 182.55 ▲ 1.15% GRUMA 280.45 ▼ 0.76% KIMBER 38.85 ▲ 1.17% SQM-B 65,055 ▲ 0.80% COPEC 6,550 ▲ 1.55% BSANTANDER 79.85 ▲ 1.06% FALABELLA 6,042 ▲ 2.08% ENELAM 84.53 — 0.00% CENCOSUD 2,010 ▼ 0.89% CMPC 1,070 ▼ 1.28% BANCO CHILE 193.50 ▲ 1.84% LATAM AIR 24.09 ▼ 0.45% YPF 82,500 ▲ 2.33% GGAL 8,275 ▲ 3.89% PAMPA 5,625 ▲ 2.74% TXAR 668.50 ▼ 1.55% ALUAR 974.00 ▲ 0.10% TGS 9,905 ▲ 2.01% CEPU 2,411 ▲ 3.03% MIRGOR 16,925 ▲ 0.89% COME 43.14 ▲ 0.63% LOMA NEGRA 3,823 ▲ 6.03% BYMA 295.00 ▲ 0.94% TELECOM ARG 4,420 ▲ 3.88% ECOPETROL 16.69 ▲ 0.97% BANCOLOMBIA 84.66 ▲ 1.22% GRUPO AVAL 5.04 ▼ 0.98% CREDICORP 393.43 ▲ 0.60% SOUTHERN COPPER 195.48 ▲ 3.97% BUENAVENTURA 32.09 ▲ 2.69% MERCADOLIBRE 1,799 ▼ 1.29% NUBANK 14.51 ▲ 0.83% XP 17.30 ▲ 2.67% PAGSEGURO 9.67 ▲ 0.94% STONE 11.36 ▲ 0.93% GLOBANT 30.67 ▼ 4.45% TECNOGLASS 45.24 ▲ 0.20% GAP AIRPORT 217.70 ▲ 0.01% ASUR 273.53 ▼ 0.52% OMA AIRPORT 105.35 ▲ 1.07% AMX ADR 26.12 ▲ 0.12% FEMSA ADR 130.96 ▲ 0.47% CEMEX ADR 12.74 ▲ 0.32% PETROBRAS ADR 18.89 ▲ 1.89% VALE ADR 14.85 ▲ 4.21% ITAU ADR 8.48 ▲ 0.95% SANTANDER BR 5.45 ▲ 0.74% AMBEV ADR 3.14 ▲ 0.96% CSN 1.09 ▲ 9.00% GERDAU 4.77 ▲ 2.69% LATAM ADR 51.22 ▼ 0.68% BTC 65,710 ▼ 1.20% ETH 1,924 ▼ 0.25% SOL 77.47 ▼ 0.82% XRP 1.13 ▼ 0.65% BNB 570.32 ▼ 0.57% ADA 0.17 ▲ 0.32% DOGE 0.07 ▼ 0.93% AVAX 6.57 ▲ 0.13% LINK 8.60 ▼ 0.57% DOT 0.83 ▼ 1.87% LTC 47.18 ▲ 0.78% BCH 218.25 ▼ 2.44% TRX 0.33 ▼ 0.13% XLM 0.19 ▼ 3.05% HBAR 0.07 ▲ 5.04% NEAR 1.86 ▼ 3.73% ATOM 1.46 ▼ 1.76% AAVE 97.75 ▲ 2.28% SELIC 14.25% EMBRAER 83.79 ▲ 1.38% EMBRAER ADR 66.05 ▲ 0.89% JBS 12.25 ▲ 2.51% JBS BDR 61.80 ▲ 2.62% MBRF3 16.03 ▲ 6.09% MBRFY 3.19 ▲ 8.14% INTER 5.69 ▲ 1.97% EGX 53,932 ▼ 0.11% USD/ZAR16.37▼ 0.62% USD/NGN 1,370 — 0.00% NIKKEI 66,535 ▲ 0.63% CSI300 4,721 ▲ 0.07% HSI 25,079 ▲ 0.75% NIFTY 23,996 ▼ 0.79% KOSPI 6,992 ▲ 2.86% JCI 6,369 ▲ 0.54% USD/JPY163.06▼ 0.07% USD/CNY6.77▲ 0.05% DAX 25,155 ▲ 0.58% CAC 8,438 ▲ 0.89% FTSE 10,717 ▲ 1.24% MIB 52,792 ▲ 0.97% IBEX 19,571 ▲ 0.99% STOXX 646.93 ▲ 0.58% EUR/USD1.14▲ 0.23% GBP/USD1.34▼ 0.34% SPX 7,499 ▼ 0.14% DJI 52,219 ▼ 0.01% NDX 28,998 ▼ 0.54% RUT 2,960 ▼ 0.92% TSX 35,485 ▲ 0.33% VIX 16.64 ▼ 2.40% USD/CAD1.41▼ 0.26% US10Y 4.6570 ▲ 0.63% IBOV 177,547.57 ▲ 2.44% IPSA 11,009.22 ▲ 0.50% IPC MEX 67,303.83 ▲ 0.88% MERVAL 3,379,771 ▲ 2.98% COLCAP 2,297.00 ▼ 0.19% BVL PERÚ 57,575.02 — — USD/BRL 5.05 ▼ 0.37% USD/MXN 17.38 ▼ 0.17% USD/CLP 937.27 ▲ 0.17% USD/COP 3,205 ▼ 1.57% USD/PEN 3.40 ▼ 0.04% USD/ARS 1,482 ▲ 0.30% USD/UYU 40.14 ▲ 1.07% USD/PYG 6,035 ▲ 1.50% USD/BOB 10.95 ▲ 3.79% USD/DOP 58.15 ▼ 0.09% USD/CRC 447.42 ▲ 1.35% USD/GTQ 7.62 ▲ 2.27% USD/HNL 26.74 ▲ 1.52% USD/NIO 36.62 ▲ 0.72% USD/VES 736.04 ▼ 0.04% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 156.98 ▲ 0.03% USD/TTD 6.71 ▲ 0.76% EUR/BRL 5.77 ▼ 0.88% BRENT 95.83 ▲ 5.30% WTI 88.16 ▲ 3.83% IRON ORE 161.91 — — COPPER 6.51 ▼ 0.07% GOLD 4,117 ▲ 1.13% SILVER 59.74 ▲ 1.54% SOY 1,242 ▲ 1.87% CORN 485.00 ▲ 7.12% WHEAT 705.50 ▲ 4.06% COFFEE 318.05 ▼ 4.19% SUGAR 14.75 ▼ 0.87% ORANGE JUICE 147.50 ▲ 2.57% COTTON 81.36 ▲ 3.04% COCOA 5,353 ▼ 4.53% BEEF 219.20 ▼ 3.30% CATTLE 336.15 ▼ 3.83% LITHIUM 69.00 ▼ 0.12% PETR4 42.58 ▲ 2.21% VALE3 75.10 ▲ 3.77% ITUB4 42.90 ▲ 0.87% BBDC4 18.97 ▲ 2.26% ABEV3 16.13 ▲ 2.09% BBAS3 21.09 ▲ 1.01% B3SA3 15.90 ▲ 4.81% WEGE3 46.74 ▲ 10.05% PRIO3 59.77 ▲ 2.73% SUZB3 42.66 ▲ 2.47% RENT3 37.14 ▲ 1.61% AZZA3 17.81 ▲ 1.89% CSAN3 3.92 ▲ 3.70% RAIZ4 0.27 — 0.00% PCAR3 2.75 ▲ 0.73% GMAT3 3.91 ▲ 2.09% PSSA3 55.45 ▲ 3.68% CVCB3 1.27 ▲ 13.39% POSI3 3.70 ▲ 0.54% SLCE3 13.96 ▲ 1.53% NATU3 8.68 ▼ 0.34% BRKM5 6.07 ▲ 6.30% RANI3 8.00 ▲ 1.39% CSNA3 5.38 ▲ 6.32% CMIN3 5.84 ▲ 4.66% USIM5 8.65 ▲ 2.25% GGBR4 24.06 ▲ 2.43% ENEV3 25.97 ▲ 2.16% CPFE3 46.71 ▲ 0.67% CMIG4 11.21 ▲ 1.72% EQTL3 39.35 ▲ 1.34% LREN3 13.54 ▲ 2.03% VIVT3 35.38 ▼ 1.17% RAIL3 13.64 ▲ 3.02% KLABIN 17.93 ▲ 1.93% RAIA DROGASIL 18.29 ▲ 0.88% RDOR3 34.49 ▲ 1.68% HAPV3 11.39 ▲ 1.33% FLRY3 16.65 ▲ 0.60% SMTO3 16.05 ▲ 3.02% UGPA3 32.83 ▲ 3.17% VBBR3 34.98 ▲ 3.03% BBSE3 42.58 ▲ 2.48% BPAC11 57.02 ▲ 2.98% CURY3 30.20 ▲ 0.83% AERI3 2.05 ▲ 0.49% VIVARA 21.55 ▲ 0.65% COMPASS 24.81 ▲ 1.51% VAMOS 3.23 ▲ 4.53% SANB11 26.95 ▼ 0.96% ASAI3 8.40 ▲ 1.82% SBSP3 29.29 ▲ 2.41% WALMEX 48.65 ▼ 1.02% GMEXICO 214.34 ▲ 2.57% FEMSA 227.98 ▲ 0.55% CEMEX 22.17 ▲ 0.45% GFNORTE 191.99 ▲ 3.33% BIMBO 60.30 ▲ 1.53% TELEVISA 9.82 ▲ 0.61% AMX 22.70 ▼ 0.26% GAP 378.40 ▼ 0.03% ASUR 273.53 ▼ 0.52% OMA 229.62 ▲ 1.49% KOF 182.55 ▲ 1.15% GRUMA 280.45 ▼ 0.76% KIMBER 38.85 ▲ 1.17% SQM-B 65,055 ▲ 0.80% COPEC 6,550 ▲ 1.55% BSANTANDER 79.85 ▲ 1.06% FALABELLA 6,042 ▲ 2.08% ENELAM 84.53 — 0.00% CENCOSUD 2,010 ▼ 0.89% CMPC 1,070 ▼ 1.28% BANCO CHILE 193.50 ▲ 1.84% LATAM AIR 24.09 ▼ 0.45% YPF 82,500 ▲ 2.33% GGAL 8,275 ▲ 3.89% PAMPA 5,625 ▲ 2.74% TXAR 668.50 ▼ 1.55% ALUAR 974.00 ▲ 0.10% TGS 9,905 ▲ 2.01% CEPU 2,411 ▲ 3.03% MIRGOR 16,925 ▲ 0.89% COME 43.14 ▲ 0.63% LOMA NEGRA 3,823 ▲ 6.03% BYMA 295.00 ▲ 0.94% TELECOM ARG 4,420 ▲ 3.88% ECOPETROL 16.69 ▲ 0.97% BANCOLOMBIA 84.66 ▲ 1.22% GRUPO AVAL 5.04 ▼ 0.98% CREDICORP 393.43 ▲ 0.60% SOUTHERN COPPER 195.48 ▲ 3.97% BUENAVENTURA 32.09 ▲ 2.69% MERCADOLIBRE 1,799 ▼ 1.29% NUBANK 14.51 ▲ 0.83% XP 17.30 ▲ 2.67% PAGSEGURO 9.67 ▲ 0.94% STONE 11.36 ▲ 0.93% GLOBANT 30.67 ▼ 4.45% TECNOGLASS 45.24 ▲ 0.20% GAP AIRPORT 217.70 ▲ 0.01% ASUR 273.53 ▼ 0.52% OMA AIRPORT 105.35 ▲ 1.07% AMX ADR 26.12 ▲ 0.12% FEMSA ADR 130.96 ▲ 0.47% CEMEX ADR 12.74 ▲ 0.32% PETROBRAS ADR 18.89 ▲ 1.89% VALE ADR 14.85 ▲ 4.21% ITAU ADR 8.48 ▲ 0.95% SANTANDER BR 5.45 ▲ 0.74% AMBEV ADR 3.14 ▲ 0.96% CSN 1.09 ▲ 9.00% GERDAU 4.77 ▲ 2.69% LATAM ADR 51.22 ▼ 0.68% BTC 65,710 ▼ 1.20% ETH 1,924 ▼ 0.25% SOL 77.47 ▼ 0.82% XRP 1.13 ▼ 0.65% BNB 570.32 ▼ 0.57% ADA 0.17 ▲ 0.32% DOGE 0.07 ▼ 0.93% AVAX 6.57 ▲ 0.13% LINK 8.60 ▼ 0.57% DOT 0.83 ▼ 1.87% LTC 47.18 ▲ 0.78% BCH 218.25 ▼ 2.44% TRX 0.33 ▼ 0.13% XLM 0.19 ▼ 3.05% HBAR 0.07 ▲ 5.04% NEAR 1.86 ▼ 3.73% ATOM 1.46 ▼ 1.76% AAVE 97.75 ▲ 2.28% SELIC 14.25% EMBRAER 83.79 ▲ 1.38% EMBRAER ADR 66.05 ▲ 0.89% JBS 12.25 ▲ 2.51% JBS BDR 61.80 ▲ 2.62% MBRF3 16.03 ▲ 6.09% MBRFY 3.19 ▲ 8.14% INTER 5.69 ▲ 1.97% EGX 53,932 ▼ 0.11% USD/ZAR 16.37 ▼ 0.24% USD/NGN 1,370 — 0.00% NIKKEI 66,535 ▲ 0.63% CSI300 4,721 ▲ 0.07% HSI 25,079 ▲ 0.75% NIFTY 23,996 ▼ 0.79% KOSPI 6,992 ▲ 2.86% JCI 6,369 ▲ 0.54% USD/JPY 163.07 ▼ 0.01% USD/CNY 6.7695 ▲ 0.08% DAX 25,155 ▲ 0.58% CAC 8,438 ▲ 0.89% FTSE 10,717 ▲ 1.24% MIB 52,792 ▲ 0.97% IBEX 19,571 ▲ 0.99% STOXX 646.93 ▲ 0.58% EUR/USD 1.1423 ▲ 0.12% GBP/USD 1.3384 ▲ 0.06% SPX 7,499 ▼ 0.14% DJI 52,219 ▼ 0.01% NDX 28,998 ▼ 0.54% RUT 2,960 ▼ 0.92% TSX 35,485 ▲ 0.33% VIX 16.64 ▼ 2.40% USD/CAD 1.4072 ▼ 0.07% US10Y 4.6570 ▲ 0.63%
since 2009
Thursday, July 23, 2026

Brazil Politics - Brazil

Brazil Loses Another Health Minister Pressured by Bolsonaro to Reopen Economy and Use Chloroquine

By · May 16, 2020 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – On Friday, May 15th, Nelson Teich, an oncologist, resigned his position as Minister of Health, less than a month after taking on the most sensitive portfolio to tackle the Covid-19 pandemic, amid public disagreements with President Jair Bolsonaro.

Teich is the second Health Minister to leave office during the spread of Covid-19, which has already caused almost 14,000 deaths in Brazil.

Nelson Teich (right) resigned less than a month after replacing Mandetta in the coronavirus pandemic. (Photo Internet Reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

With a brief administration marked by the strong influence of the military and the delay in measures to tackle the crisis, the oncologist took over the post left by ex-Minister Luiz Henrique Mandetta with the mission of combining social distancing measures with the reopening of the economy, as Bolsonaro had been pressuring.

At first, he pointed out that he would not make abrupt changes in the Ministry’s policy, but that he would instead draw up a plan to combine the two, and pledged to be guided by science.

But in a short time, he saw his management bruised – under criticism from state and municipal health secretaries – and found himself isolated. Teich took office as a Minister, posing as a mediator after a political crisis. He accepted that the President, and not himself, should choose the number two in the Ministry of Health, General Eduardo Pazuello.

Unlike Mandetta, he avoided publicly criticizing the president and always reiterated that he would not comment on the behavior of the president during the pandemic. However, the disagreements between the now ex-Minister and Bolsonaro over measures to tackle the greatest health crisis in decades, became more apparent in recent days.

Last week, he was surprised when, during a press conference, he was asked by journalists about a Presidential decree that included declaring services in beauty salons, barbershops, and gyms as essential activities.

He had not even been consulted about the measure. Nevertheless, he considered it to be Bolsonaro and the Ministry of Economy’s decision. He argued that the role of the Ministry of Health was to help them see the best way to achieve this opening “by protecting the people”.

Last Thursday, May 14th, Bolsonaro further increased the pressure on his Minister of Health and demanded that Teich recommend the use of chloroquine for the treatment of patients infected with the novel coronavirus at the very early stages of Covid-19.

Currently, the Ministry of Health only authorizes the use of the drug provided there is a mutual agreement between doctor and patient, as the effectiveness of the drug in treating the disease has not yet been scientifically proven, and doctors alert to the risks of its severe side effects.

Bolsonaro increased the pressure on his Minister of Health to recommend the use of chloroquine in Covid-19 patients. (Photo Internet Reproduction)

Teich was in line with a resolution by the Federal Council of Medicine. “Now, they voted for me to decide and this chloroquine issue goes through me”, argued the President, in an online meeting with major entrepreneurs, in which he voiced his dissatisfaction with the Minister’s lack of action on the issue and pledged that the protocol on chloroquine would change.

To allies, Teich had been complaining that it was very difficult to heed the President’s wishes while respecting what science prescribes. Repeatedly, the Minister objected to deliberately recommending the use of chloroquine before there were studies providing greater safety for its use in the treatment of Covid-19.

“Chloroquine is still uncertain today. There were initial studies that suggested benefits, but there are studies today that say otherwise,” the then minister said at a press conference on April 29th. “The preliminary data from China is that it has had a high mortality rate and that the drug will not be a watershed in relation to the disease,” he added.

He also faced criticism from state and municipal health secretaries, who complained of being excluded from the national decision-making process when the SUS [national health system] has its management shared among them. They also complained that the Federal Government had been slow to transfer medical supplies while the epidemic was spreading in the country.

When he took over the Ministry, the oncologist pledged to conduct mass population testing. Days later, he explained that mass testing does not mean testing the entire population. Teich doubled the number of tests Mandetta had promised and said the country would reach 46 million tests.

But by Friday, the government had only managed to distribute half of the 17 million tests expected to be delivered by the end of May.

The Minister also changed the platforms with data on the epidemic’s progression in the country, but was unsuccessful in providing the data promised since the onset of the crisis, such as the total number of intensive care beds and their occupation in both the public and private hospital networks.

Teich’s major project was the development of a risk matrix to help managers decide whether to relax or tighten social distancing measures. The tool was developed but was rejected by state and municipal health managers. They stated that they would only discuss a reopening – advocated by President Bolsonaro – when there was evidence that the coronavirus contagion was slowing in the country.

“It is inopportune to discuss relaxing isolation when we see the death toll rise,” criticized the president of the Council of State Secretaries for Health, Alberto Beltrame. Teich vowed that he would engage in dialogue with the managers, but felt increasing pressure from the President.

Since taking over the Ministry, Teich has also been criticized for his limited awareness of the National Health System (SUS). “The Minister has difficulties, he does not have a full grasp of what the SUS is and this creates additional challenges. Things have been flowing very slowly,” Beltrame said in an interview.

An oncologist and private sector entrepreneur, Teich defended himself on social media and said he had started his career in the public sector. While health care systems collapsed in several states, the ex-Minister opposed the suggestion of establishing a single wait list for ICU beds.

Officials say almost 14,000 people have died in Brazil from Covid-19, though some experts say the figure is significantly higher due to insufficient testing. (Photo Internet Reproduction)

The new Minister to be appointed by Bolsonaro will take over as the country is experiencing a steep upward trend of the spread of Covid-19, with more than 200,000 people infected. And he or she will need to provide answers quickly to states and municipalities, which often complain about delays in the transfer of ventilators, personal protective equipment, and medical supplies.

Source: El País

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.